Saeed Yazdankhah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saeed Yazdankhah has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ahmadreza Assareh
Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 shared publications - Shahla Majidi
Department of Cardiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 shared publications Nasim Nasehi
Department of Cardiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 shared publicationsAbdalrahim Masjedizade
Research Center for Infectious Diseases of Digestive System, Alimentary Tract Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
1 shared publication- Ahmad Ahmadzadeh
Health Research Institute, Thalassemia and Hemoglobinopathies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
1 shared publication Ali Kardooni
Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
1 shared publication
Latest Publications
- Open Access
- 9 March 2025
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 32 (1) , 1-7
The Role of Short-term Low-Dose Atorvastatin in Improving Endothelial Function in Normolipidemic Heart Failure with Preserved Ejection Fraction
Background: Heart failure with preserved ejection fraction (HFpEF) imposes a heavy burden on Iran’s health system. Although therapeutics are prescribed for HFpEF, no evidence-based therapy has been generally accepted. Endothelial dysfunction is currently recognized as a promising therapeutic target for patients with HFpEF. Methods: A total of 40 patients who referred to the echocardiography clinic of Imam Khomeini hospital in Ahvaz participated in this randomized clinical trial. Echocardiographic and clinical criteria for HFpEF and normal coronary angiography were recorded in all subjects. The patients did not have indications of statin therapy or a prior history of statin consumption. They were randomly assigned to the atorvastatin (20 mg once daily) and placebo groups (n=20 per group). Flow-mediated dilatation (FMD) of the brachial artery was measured in the two groups before the trial and after the two-month treatment period. Clinical trial registration is available from: https://irct.behdasht.gov.ir/, (identifier: IRCT2015010320538N1). Results: The patients’ mean age was 65 years, 40% were male, and 60% were female. There was a significant improvement in FMD only in the atorvastatin group (+41.5% in males and+18.25% in females) (P<0.001). The low-density lipoprotein (LDL) level significantly decreased after treatment in the atorvastatin group but not in the placebo group. The variation in FMD was not dramatically associated with the reduction in serum LDL in the two groups. Conclusion: Atorvastatin has advantageous effects on the vascular endothelial function of HFpEF, and this effect is not associated with its lipid-lowering properties.
- 9 March 2025
- Published by Maad Rayan Publishing Company in Journal of Kerman University of Medical Sciences
- Vol. 32 (1) , 1-7
Open AccessThe Role of Short-term Low-Dose Atorvastatin in Improving Endothelial Function in Normolipidemic Heart Failure with Preserved Ejection Fraction
Background: Heart failure with preserved ejection fraction (HFpEF) imposes a heavy burden on Iran’s health system. Although therapeutics are prescribed for HFpEF, no evidence-based therapy has been generally accepted. Endothelial dysfunction is currently recognized as a promising therapeutic target for patients with HFpEF. Methods: A total of 40 patients who referred to the echocardiography clinic of Imam Khomeini hospital in Ahvaz participated in this randomized clinical trial. Echocardiographic and clinical criteria for HFpEF and normal coronary angiography were recorded in all subjects. The patients did not have indications of statin therapy or a prior history of statin consumption. They were randomly assigned to the atorvastatin (20 mg once daily) and placebo groups (n=20 per group). Flow-mediated dilatation (FMD) of the brachial artery was measured in the two groups before the trial and after the two-month treatment period. Clinical trial registration is available from: https://irct.behdasht.gov.ir/, (identifier: IRCT2015010320538N1). Results: The patients’ mean age was 65 years, 40% were male, and 60% were female. There was a significant improvement in FMD only in the atorvastatin group (+41.5% in males and+18.25% in females) (P<0.001). The low-density lipoprotein (LDL) level significantly decreased after treatment in the atorvastatin group but not in the placebo group. The variation in FMD was not dramatically associated with the reduction in serum LDL in the two groups. Conclusion: Atorvastatin has advantageous effects on the vascular endothelial function of HFpEF, and this effect is not associated with its lipid-lowering properties.
- Open Access
- 31 December 2018
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 16 (4) , e25
Circulating HOTAIR LncRNA Is Potentially Up-regulated in Coronary Artery Disease
Coronary artery disease (CAD) is one of the leading causes of death and disability all around the world. Recent studies have revealed that aberrantly regulated long non-coding RNA (lncRNA) as one of the main classes of cellular transcript play a key regulatory role in transcriptional and epigenetic pathways. Recent reports have demonstrated circulating long noncoding RNAs in blood can be potential biomarkers for CAD. HOTAIR is one of the most cited lncRNAs with a critical role in initiation and progression of the gene expression regulation. Recent research on the role of the HOTAIR in cardiovascular disease lays the basis for the development of new studies considering this lncRNA as a potential biomarker and therapeutic target in CAD. In this study, we aimed to compare the expression of HOTAIR lncRNA in the blood samples of patients with CAD and control samples. The expression level was examined by semi-quantitative reverse transcriptase polymerase chain reaction technique. Our data show that expression of HOTAIR is up-regulated in blood samples of patients with CAD.
- 31 December 2018
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 16 (4) , e25
Open AccessCirculating HOTAIR LncRNA Is Potentially Up-regulated in Coronary Artery Disease
Coronary artery disease (CAD) is one of the leading causes of death and disability all around the world. Recent studies have revealed that aberrantly regulated long non-coding RNA (lncRNA) as one of the main classes of cellular transcript play a key regulatory role in transcriptional and epigenetic pathways. Recent reports have demonstrated circulating long noncoding RNAs in blood can be potential biomarkers for CAD. HOTAIR is one of the most cited lncRNAs with a critical role in initiation and progression of the gene expression regulation. Recent research on the role of the HOTAIR in cardiovascular disease lays the basis for the development of new studies considering this lncRNA as a potential biomarker and therapeutic target in CAD. In this study, we aimed to compare the expression of HOTAIR lncRNA in the blood samples of patients with CAD and control samples. The expression level was examined by semi-quantitative reverse transcriptase polymerase chain reaction technique. Our data show that expression of HOTAIR is up-regulated in blood samples of patients with CAD.
- Open Access
- 2 October 2017
- Published by Elsevier in Data in Brief
- Vol. 15, 478-482
The effect of reducing the incidence of gastrointestinal complications in patients treated with aspirin, referred to Imam Hospital, of Ahvaz, Iran
- 2 October 2017
- Published by Elsevier in Data in Brief
- Vol. 15, 478-482
Open AccessThe effect of reducing the incidence of gastrointestinal complications in patients treated with aspirin, referred to Imam Hospital, of Ahvaz, Iran
- Open Access
- 1 January 2016
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 5 (1) , 21-24
Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
- 1 January 2016
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 5 (1) , 21-24
Open AccessContrast induced nephropathy among patients with normal renal function undergoing coronary angiography
Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
- Open Access
- 3 April 2015
- Vol. 10 (2) , 80-84
Changes in Heart Rate Variability Parameters after Elective Percutaneous Coronary Intervention
Background: Patients with chronic stable angina often have a state of sympathetic hyperactivity. It is considered associated with myocardial ischemia and disappears after ischemia elimination. The aim of this study was to investigate the changes in heart rate variability parameters, a noninvasive technique for the evaluation of the autonomic nervous system activity, after successful revascularization in these patients to evaluate this theory.
- 3 April 2015
- Vol. 10 (2) , 80-84
Open AccessChanges in Heart Rate Variability Parameters after Elective Percutaneous Coronary Intervention
Background: Patients with chronic stable angina often have a state of sympathetic hyperactivity. It is considered associated with myocardial ischemia and disappears after ischemia elimination. The aim of this study was to investigate the changes in heart rate variability parameters, a noninvasive technique for the evaluation of the autonomic nervous system activity, after successful revascularization in these patients to evaluate this theory.
- Open Access
- 22 September 2013
- Published by Hindawi Limited in Journal of Angiology
- Vol. 2013, 1-6
Study of the Influence of Upper Extremities Variation on Transradial Success
Background. To investigate whether the presence of arterial anomalies in upper limb arteries can influence the success rate of transradial coronary angiography. Methods. retrograde transarterial sheath injection was done in patients with transradial coronary angiography. Arterial anomalies in the upper limb are evaluated in these patients. There are ten brachial (5.4%), 7 radial (4/2%), 5 subclavian (3%), and 3 brachiocephalic arteries (1.8%). There also were 4 loops in ulnar artery (2.4%) and one in radial (0.6%). Except cannulation time (), there were associations between anomalies and other times () and contrast volume used (). Anomalies did not have any effect on procedural success rate and just in one patient because of subclavian loop,procedure changed to femoral approach (). Discussion. Patients without upper extremities anomalies in comparison with patients with anomalies had significantly shorter periods for angiographic time, catheterization time, and fluoroscopic time. We recommend femoral catheterization instead of radial catheterization in patients with upper extremities anomalies.
- 22 September 2013
- Published by Hindawi Limited in Journal of Angiology
- Vol. 2013, 1-6
Open AccessStudy of the Influence of Upper Extremities Variation on Transradial Success
Background. To investigate whether the presence of arterial anomalies in upper limb arteries can influence the success rate of transradial coronary angiography. Methods. retrograde transarterial sheath injection was done in patients with transradial coronary angiography. Arterial anomalies in the upper limb are evaluated in these patients. There are ten brachial (5.4%), 7 radial (4/2%), 5 subclavian (3%), and 3 brachiocephalic arteries (1.8%). There also were 4 loops in ulnar artery (2.4%) and one in radial (0.6%). Except cannulation time (), there were associations between anomalies and other times () and contrast volume used (). Anomalies did not have any effect on procedural success rate and just in one patient because of subclavian loop,procedure changed to femoral approach (). Discussion. Patients without upper extremities anomalies in comparison with patients with anomalies had significantly shorter periods for angiographic time, catheterization time, and fluoroscopic time. We recommend femoral catheterization instead of radial catheterization in patients with upper extremities anomalies.
- 1 May 2013
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 22 (5) , 346-351
The Prevalence and Prognostic Role of Vitamin D Deficiency in Patients with Acute Coronary Syndrome: A Single Centre Study in South-West of Iran
- 1 May 2013
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 22 (5) , 346-351
The Prevalence and Prognostic Role of Vitamin D Deficiency in Patients with Acute Coronary Syndrome: A Single Centre Study in South-West of Iran
- Open Access
- 1 September 2012
- Vol. 17 (9) , 859-864
Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level
Background: Definitions of chronic kidney disease (CKD) in many catheterization laboratories have relied on the serum creatinine (Scr) rather than glomerular filtration rate (GFR). Regarding that CKD is the primary predisposing factor for contrast induced nephropathy (CIN), we compared the sensitivity of calculated GFR by 24-h Urine creatinine with Cockcroft-Gault (CG) equation and Scr level to define at risk patients for CIN who were undergone coronary angiography (CAG). Materials and Methods: Two hundred fifty four subjects who were candidate for CAG and had normal creatinine level were enrolled. Before CAG, GFR was calculated from a 24-h urine collection, CG equation and a single Scr sample regarding to previously described protocol. Contrast volume used for each case <100 ml. CIN was defined as a 0.5 mg/dL or 25% elevation in the Scr. Results: CIN occurred in 10.6%. Baseline GFR, the volume of contrast agent, and diabetes were the independent risk factors for CIN. GFR was less than 60 ml/min/1.73 m2 in 28% and 23.2% of patients regarding to 24-h urine creatinine and CG equation, respectively. In CIN prediction, 24-h urine creatinine estimated GFR had 85.2%, 59.3% and CG equation GFR had 78.9%, 81.1% sensitivity and specificity, respectively. Conclusion: Although, GFR estimated by CG equation has less sensitivity than GFR calculated from 24-h creatinine in CIN probability, but it is better than Scr alone and because of cost-effectiveness and convenience using of this method, we suggest at least using CG equation for GFR calculation before CIN, especially in diabetic and/or older than 60 years cases.
- 1 September 2012
- Vol. 17 (9) , 859-864
Open AccessDefining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level
Background: Definitions of chronic kidney disease (CKD) in many catheterization laboratories have relied on the serum creatinine (Scr) rather than glomerular filtration rate (GFR). Regarding that CKD is the primary predisposing factor for contrast induced nephropathy (CIN), we compared the sensitivity of calculated GFR by 24-h Urine creatinine with Cockcroft-Gault (CG) equation and Scr level to define at risk patients for CIN who were undergone coronary angiography (CAG). Materials and Methods: Two hundred fifty four subjects who were candidate for CAG and had normal creatinine level were enrolled. Before CAG, GFR was calculated from a 24-h urine collection, CG equation and a single Scr sample regarding to previously described protocol. Contrast volume used for each case <100 ml. CIN was defined as a 0.5 mg/dL or 25% elevation in the Scr. Results: CIN occurred in 10.6%. Baseline GFR, the volume of contrast agent, and diabetes were the independent risk factors for CIN. GFR was less than 60 ml/min/1.73 m2 in 28% and 23.2% of patients regarding to 24-h urine creatinine and CG equation, respectively. In CIN prediction, 24-h urine creatinine estimated GFR had 85.2%, 59.3% and CG equation GFR had 78.9%, 81.1% sensitivity and specificity, respectively. Conclusion: Although, GFR estimated by CG equation has less sensitivity than GFR calculated from 24-h creatinine in CIN probability, but it is better than Scr alone and because of cost-effectiveness and convenience using of this method, we suggest at least using CG equation for GFR calculation before CIN, especially in diabetic and/or older than 60 years cases.